Edition:
United States

DexCom Inc (DXCM.O)

DXCM.O on Nasdaq

65.01USD
9 Dec 2016
Change (% chg)

$0.40 (+0.62%)
Prev Close
$64.61
Open
$64.46
Day's High
$65.64
Day's Low
$64.23
Volume
754,792
Avg. Vol
1,061,705
52-wk High
$96.38
52-wk Low
$47.92

Latest Key Developments (Source: Significant Developments)

Dexcom Inc Reports second quarter 2016 financial results
Tuesday, 2 Aug 2016 04:01pm EDT 

Dexcom Inc : Q2 revenue $137.3 million versus I/B/E/S view $132.6 million . Q2 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S . Dexcom, Inc. Reports second quarter 2016 financial results .Q2 GAAP loss per share $0.24.  Full Article

Dexcom Inc says FDA posts briefing documents ahead of advisory committee meeting
Tuesday, 19 Jul 2016 08:32am EDT 

Dexcom Inc : Dexcom Inc says FDA posts briefing documents ahead of advisory committee meeting .Dexcom Inc says clinical chemistry and clinical toxicology devices panel to convene on July 21.  Full Article

Dexcom to expand manufacturing operations to Greater Phoenix
Monday, 20 Jun 2016 08:10am EDT 

Dexcom Inc : Dexcom to expand manufacturing operations to Greater Phoenix, Arizona .Dexcom Inc says expect initial manufacturing operations in facility to commence in Q2 of 2017.  Full Article

Dexcom says entered into $200 mln revolving credit agreement
Monday, 20 Jun 2016 06:06am EDT 

Dexcom Inc : On june 17, entered into $200 million revolving credit agreement with jpmorgan chase bank, n.a., bank of america, silicon valley bank,union bank . Says as Of June 17, 2016, Dexcom had no outstanding loans under credit agreement - Sec filing . Credit agreement provides a subfacility of up to $10 million for letters of credit . Dexcom inc says credit agreement matures on june 17, 2021 . Credit agreement provides a $25 million sublimit for borrowings in canadian dollars, euros, british pounds, swedish krona, japanese yen .Has option to increase maximum principal amount available under credit agreement by up to an additional $100 million.  Full Article

DexCom to Collaborate with the Life Sciences Team at Google on the development of technologies to change the future of diabetes management
Tuesday, 11 Aug 2015 08:00am EDT 

DexCom Inc:Announces that it has entered into an agreement with the life sciences team at Google to jointly develop a series of CGM products that are designed to be smaller and less expensive than existing technologies.Says these new products will incorporate Google's miniaturized electronics platform with DexCom's sensor technology.Says this collaboration also provides an opportunity to better utilize the data generated by these CGM products to significantly improve the outcomes and reduce the costs associated with diabetes care.  Full Article

Dexcom Inc reaffirms FY 2015 revenue guidance-conference call
Wednesday, 29 Apr 2015 04:30pm EDT 

Dexcom Inc:Says it gave product revenue guidance for FY 2015 of between $340 million and $360 million, and it remain quite comfortable with that range.FY 2015 revenue of $360 million - Thomson Reuters I/B/E/S.  Full Article

Dexcom Inc reaffirms FY 2015 revenue guidance - Conference Call
Wednesday, 25 Feb 2015 09:30pm EST 

Dexcom Inc:Says it gave product revenue guidance for FY 2015 of between $340 million and $360 million, and it remain quite comfortable with that range.FY 2015 revenue of $357 million - Thomson Reuters I/B/E/S.  Full Article

Dexcom Inc announces continued partnership with NASCAR Driver Ryan Reed
Thursday, 19 Feb 2015 08:30am EST 

Dexcom Inc:Announces that they are continuing their partnership with NASCAR driver Ryan Reed, the face of the American Diabetes Association's national diabetes awareness initiative, Drive to Stop Diabetes presented by Lilly Diabetes.Through the collaboration, Dexcom will continue its support of Ryan Reed while reinforcing the partners' common quest of creating awareness of CGM among people with diabetes.  Full Article

FDA approves DexCom G4 Platinum Continuous Glucose Monitoring System
Monday, 26 Jan 2015 08:00am EST 

DexCom Inc:Receives U.S. Food and Drug Administration (FDA) approval for its Dexcom G4((reg))PLATINUM Continuous Glucose Monitoring System with Share.  Full Article

DexCom Inc gives FY 2015 revenue guidance in line with analysts' estimates - Conference Call
Tuesday, 13 Jan 2015 06:30pm EST 

DexCom Inc:Expects FY 2015 revenue guidance in a range of $340 million to $360 million.FY 2015 revenue of $351 million - Thomson Reuters I/B/E/S.  Full Article

BRIEF-DexCom Q3 GAAP loss per share $0.22

* Q3 revenue $148.6 million versus I/B/E/S view $146.3 million